Guide for Authors

Guide for Authors

 

Scope of the Journal: The Iranian Journal of Basic Medical Sciences (IJBMS) is a peer-reviewed, monthly publication by Mashhad University of Medical Sciences (MUMS), Mashhad, Iran. The Journal of "IJBMS” is a modern forum for scientific communication. Data and information, useful to investigators in any discipline in basic medical sciences mainly including Anatomical Sciences, Biochemistry, Genetics, Immunology, Microbiology, Pathology, Pharmacology, Pharmaceutical Sciences, and Physiology, will be published after they have been peer reviewed.

  

  • Case reports and epidemiological studies are beyond the scope of the journal.
                                                           The rejection rate of the manuscripts is currently about 80%.

 

 A. General Policy:

Manuscripts, or the essence of their content, must be previously unpublished and should not be under simultaneous consideration by another Journal. By virtue of the submitted manuscript, the corresponding author acknowledges that all the co-authors have seen and approved the final version of the manuscript. Manuscripts are only accepted for publication on the understanding that the authors will permit editorial amendments, though proofs will always be submitted to the corresponding author before being sent finally to press. The decision to accept a contribution rests with the Editorial Board of the IJBMS.

 "The reviewing and publishing process depends on the quality of your study as well as the English accuracy of your manuscript.

 Article types: Manuscripts will be considered for publication in the form of original articles, short communications, review, and editorial articles. The work should be original or a thorough by an authoritative person in a pertinent field.

 

B. Ethical Consideration

This journal follows International Committee of Medical Journal Editors (ICMJE)‘s Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals.

If research misconduct, fraud or plagiarism is suspected, editors will follow the Committee on Publication Ethics (COPE) guidelines and reserve the rights to inform authors or their institution.More details are available from Publication Ethics. Please read these instructions before submitting your article.

Study design and ethical approval: Good research should be well justified, well planned, appropriately designed, and ethically approved. To conduct research to a lower standard may constitute misconduct. The authors are responsible for the whole scientific content as well as the accuracy of the bibliographic information.

Data analysis: Data should be appropriately analyzed, but inappropriate analysis does not necessarily amount to misconduct. Fabrication and falsification of data do constitute misconduct.

Authorship: As stated in the ICMJE recommendations, credit for authorship requires:

(1) Significant contributions to conceptualization and design; or the acquisition, analysis, or interpretation of the data,

(2) The drafting of the article or critical revision for important intellectual content,

(3) Final approval of the version to be published,

(4) All authors take responsibility for the content of the submitted manuscript,

 

Therefore, all the authors should complete the "Authors' Contributions Statement" file.

 

No prior publication or duplicate submissions: Manuscripts are considered for publication only if they are not under consideration by other journals and have not been published previously in the same or substantially similar form. If a prior or duplicate publication be discovered, the Editor will address the matter with the affected author/s and the other journal’s editor following guidelines published by the ICJME and by the COPE.

Conflicts of interest: Conflicts of interest comprise those which may not be fully apparent and which may influence the judgment of author, reviewers, and editors. They have been described as those which, when revealed later, would make a reasonable reader feel misled or deceived. They may be personal, commercial, political, academic or financial. “Financial” interests may include employment, research funding, stock or share ownership, payment for lectures or travel, consultancies and company support for staff.

Peer review: This journal uses Double-blind peer review, which means that both the reviewer and author identities are concealed from the reviewers, and vice versa, throughout the review process. To facilitate this, authors need to ensure that their manuscripts are prepared in a way that does not give away their identity. Authors have the right to communicate to the editor if they do not wish their manuscript to be reviewed by a particular reviewer because of potential conflicts of interest. In order to ensure the integrity of the scholarly record, IJBMS follows the COPE ethical guidelines for peer reviewers

Redundant publication: Redundant publication occurs when two or more papers, without full cross reference, share the same hypothesis, data, discussion points, or conclusions. In such cases, the manuscript will be rejected.

Plagiarism: Plagiarism ranges from the unreferenced use of others’ published and unpublished ideas, including research grant applications to submission under “new” authorship of a complete paper, sometimes in a different language. It may occur at any stage of planning, research, writing, or publication: it applies to print and electronic versions. All the manuscript submitted to IJBMS are checked by authenticate for possible plagiarism. The authors are expected to check their manuscript for plagiarism before submission.

Retractions: IJBMS is committed to maintaining the integrity of the scholarly record, therefore on occasion, it may be necessary to retract articles. IJBMS considers publishing retractions for articles according to COPE guidelines for retracting articles.

Human and animal studies: All manuscripts reporting the results of experimental investigations involving human subjects should include a statement confirming the informed consent was obtained from each subject or subject’s guardian. All animal or human studies should be used after approval of the experimental protocol by a local ethics committee.

 

C. Manuscript Preparation

The authors are requested to submit their manuscript via the following link:

http://ijbms.mums.ac.ir/contacts?_action=signup

Manuscripts should be prepared in accordance with the “Uniform Requirements for Manuscripts Submission to Biomedical Journals” proclaimed by the International Committee of Medical Journal Editors (http://www.icmje.org/recommendations/).

Corresponding author is the main owner of the article so she/he can withdraw the article when it is incomplete (before entering the review process or when a revision is asked for) by submitting a letter to the editorial office. The reasons for the request of withdrawal must be well-founded and the process should be conducted in line with the COPE publication ethics.

1. After passing the reviewing process, the research manuscripts addressing original work for rapid dissemination (e.g. total plant extract), controversial opinions or “Negative” results are often published as short communication. Short Communications will appear at the end of the topical sections in the journal table of contents.

2. For review articles, the authors are requested to provide at least three published articles in the related field of their submitted manuscript in the references section.

3. Manuscripts should be typed on A4 size paper in clear, concise English, double-spaced. Authors are requested to reserve margins of at least 2.5 cm all around the paper. Original drawings of photos, tables and figures should be furnished together with the manuscripts.

4. Manuscripts should be kept to a minimum length and should be subdivided into labeled sections (Title page, Abstract, Keywords, Introduction, Materials and Methods, Results, Discussion, Conclusion, Acknowledgment, and References).

5. A title page is to be provided and should include the title of the article, authors’ names with full first name (with degrees), authors’ affiliation, suggested running title and corresponding author. The affiliation should comprise the department, institution (usually university or company), city and state (or nation).

  • The suggested running title should be less than 50 characters (including spaces) and should comprise the article title or an abbreviated version thereof. For office purposes, the title page should include the name and complete mailing address, telephone and fax number, and email of the corresponding author.
  • The "corresponding author" and "first author" must have an ORCID ID.

6. An abstract no longer than 250 words for reviews and research articles is to be provided as the second page. Abstract should be structured as objective(s) (including purpose setting), materials and methods, results, and conclusion. The abstract of the review articles are not structured.

7. A list of 5-8 keywords, chosen from the Medical Subject Headings (MeSH) list, is to be provided directly below the abstract. Keywords should express the precise content of the manuscript, as they are used for indexing purposes. Provide abbreviations and nomenclature list in an alphabetical order and non-standard abbreviations contained in the manuscript (excluding references) with definitions after the keywords. Use abbreviations sparingly and only when necessary to save space, and to avoid repeating long chemical names or therapeutic regimes.

8. Tables in limited numbers should be self-explanatory, clearly arranged, and supplemental to the text. The captions should be placed above.

9. Figures should be utilized only if they augment understandability of the text. The same data should not be presented in tables, figures and text, simultaneously. The captions should be placed below. Drawings and graphs should be professionally prepared with a minimum resolution of 300 DPI. In a figure or table, define the abbreviations used in a footnote. 

10. Abbreviations must be defined at their first use in the manuscript. Please consider the consistency of abbreviations throughout the whole manuscript. For Gene and Protein Names please follow the International Protein Nomenclature Guidelines: https://www.ncbi.nlm.nih.gov/genome/doc/internatprot_nomenguide/

11. Authors should disclose, at the time of submission, information on interests that may influence the manuscript results and conclusions.

12. Acknowledgments, sponsorship or grants should be written after the main text and before the references.

13. References in limited numbers and up-to-dated must be numbered consecutively in order of citation in the text (number in parentheses). Periodical titles should be abbreviated according to the PubMed Journals Database (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=journals). Print surnames and initials of all authors when there are six or less. In the case of seven or more authors, the names of the first six authors followed by et al. (Italic) should be listed. Listed below are references to a Journal, a chapter in a book and a book, respectively, in correct style (according to Vancouver style):

  • Amiri N, Ajami S, Shahroodi A,  Jannatabadib N, Amiri Darbana Sh,  Fazly Bazzaz BS, et al. Teicoplanin-loaded chitosan-PEO nanofibers for local antibiotic delivery and wound healing. Int J Biol Macromol 2020; 162: 645–656.
  • Ghorbani M, Baharara J, Kerachian MA. Could high serum folate be associated with adverse effects? Iran J Basic Med Sci 2020; 23: 1499-1500.
  • Alavi MS, Karimi G, Roohbakhsh A. The role of orphan G protein-coupled receptors in the pathophysiology of multiple sclerosis: A review. Life Sci 2019; 224: 33-40.
  • Arabi L, Ho JQ, Javdani N, Jones S, Chen I, Sharaf M, et al. Nanoparticulate systems for sustained delivery of paracrine factors. In: Mahmoudi M, editor. Nanomedicine for Ischemic Cardiomyopathy Progress, Opportunities, and Challenges. 1st ed. Academic Press Inc; 2020.p. 157-169.
  • Balali-Mood M, Abdollahi M. Basic and Clinical Toxicology of Organophosphorus Compounds. 1st ed. Springer; 2014

New: The EndNote output style for IJBMS' current reference style can be found here

14. Copyright: As an open-access journal, IJBMS uses licenses that keep the copyright with the author, but the author transfers all commercial exploitation rights to the publisher. The author(s) can post a copy of the published article on his/her own website or his/her institution’s website with no permission, provided that full citation of the journal and a link to the IJBMS website are included. Also, it can be used in educational materials by author(s) with citation of the IJBMS. The author(s) may republish the article in a book written or edited by himself/herself without permission, but with full acknowledgment of the first publisher.

15. The editor-in-chief may reject manuscripts prior to peer review if they are beyond the scope of the journal or do not comply with the instructions for authors.

16. Changes to authorship: Authors are expected to consider the list and order of authors before submitting the manuscript.

17. IJBMS follows the suggested process by COPE for handling complaints and appeals.

 

D. Article-Processing Charges

Starting with July 2020 IJBMS levies an article-processing charge of 15.000.000 Rls. for each original and short communication article accepted for publication. Please note that these charges apply only to accepted articles of Iranian authors. All other articles are exempt from these charges.

 

 

Bibi Sedigheh Fazly Bazzaz, MSc, PhD

Editor in-Chief

Iranian Journal of Basic Medical Sciences

P.O. Box: 91775-1365

Email: fazlis@mums.ac.ir; jbms@mums.ac.ir

Tel: +98(051)31801510 (Please call from 09:00 -10:30)

URL: pharmacy.mums.ac.ir/index.php/component/content/article/43-persian-category/991-drfazli,1